Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Christmas flights 2026: KAYAK reveals fares down up to 39% from the UK
-
Removal of Listing of Ordinary C Shares
-
63/2026・Trifork Group: Weekly report on share buyback
-
Share repurchase programme: Transactions of week 42 2026
-
Share buyback programme – week 42
-
AB Akola Group Increases Its Investment in OMG Bubble Tea and Acquires a Controlling Stake
-
‘Global Perspectives on China’ Dialogue on GDI held in Beijing
-
Expansion of the security segment wholesale business through the acquisition of shares in companies
-
The Smart Luggage at the 140th Canton Fair:Airwheel 20inch Carry-On Hand Scooter Ai Wheel Robot Cabin Luxury Suitcase Takes Smart Travel to the Next Level
-
Exor Press Release - Periodic Report on the Buyback Program
-
Prepayments, Realkredit Danmark A/S
-
RAMSAY GENERALE DE SANTE : Availability of the 2026 URD - Evolution in the Governance - Annual General meeting on 4th December 2026
-
Share Buy-back Programme – Transactions Week 42
-
Egide - Half-year results at June 30, 2026: Net loss more than halved, amounting to €0.87m, Net financial debt reduced to €4.99m
-
Oculis lýkur slembiröðun í PREDICT-1 skráningarrannsókninni á Licaminlimab við TNFR1-miðluðum augnþurrki
-
Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease
-
tpay Selected as Vodafone Qatar’s Direct Operator Billing Aggregator
-
NBPE Announces Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
ALSTOM S.A: Alstom secures a first tranche order worth approximately €800 million in Vietnam
-
Nouscom Raises €120 Million ($135 Million) in Oversubscribed Series D Financing and will Present Long-Term Cancer Interception Clinical Data in Lynch Syndrome Carriers at ESMO
-
MKI Global Partners expands into emerging markets with focus on Latin America
-
OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
-
Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
-
Cabka’s emission reduction targets validated by the Science Based Targets initiative
-
Ekalia takes an important step in the deployment of Astatine-211 in the United States through a collaboration agreement with Telix
-
OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
-
4th Liangzhu Forum Opens in Hangzhou to Facilitate Global Heritage Dialogue
-
Red Cat Announces Proposed Voluntary Public Purchase Offer for Steyr Motors
-
JJP Biologics Doses the First Patients in Phase 1b Clinical Trial of Nebaprubart in Rheumatoid Arthritis (RA)
-
Start of Day Message
-
RUBIS ANNOUNCES A PROPOSAL TO CONVERT THE GROUP INTO A JOINT-STOCK COMPANY (SOCIÉTÉ ANONYME)
-
Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830
-
Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio
-
Aktsiaselts Infortar own share acquisition transactions
-
Ackermans & van Haaren increases its stake in Van Moer Logistics to 40%
-
IBA launches NEPTIS® Perform Duo, one synthesizer module from tracer development to routine production
-
Mowi ASA (OSE:MOWI): Q3 2026 Trading update
-
Brook StarRay Wireless Controller Now Available — Native PS5 Support Meets Xbox-Style Control
-
‘China Through Overseas Eyes’ aesthetics forum held online
-
Intelligent Scopes Unveils the ISC 100: The Solution Enabling Urology AI to Work Beside Any Cystoscopy Tower — No Replacement, No Rewiring, No Cloud
-
FOXWELL Shares Pre-Winter Vehicle Diagnostic Recommendations for Fall Car Care Month
-
Crypto News: AlphaPepe Presale Nears Stage Sell Out After $3M Raised as XRP Price Prediction Eyes $27
-
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
-
FREELANDER Joins 2026 Chery International User Summit with a Day-and-Night Programme on 19 October
-
Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstract
-
Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress
-
Cambria Gold Mines Intersects 98.56 g/t Gold over 8.2 Metres at the Silver Coin Deposit, Premier Gold Project
-
Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)
-
JUST Completes 5th JST Buyback & Burn: Over 170M Tokens (~$23.53M) Burned Ahead of Major Deflationary Upgrade


